Sativex
Sativex is a pharmaceutical drug with 36 clinical trials. Historical success rate of 93.5%.
Success Metrics
Based on 29 completed trials
Phase Distribution
Phase Distribution
12
Early Stage
2
Mid Stage
19
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.3%
29 of 34 finished
14.7%
5 ended early
0
trials recruiting
36
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)
A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.
Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy
A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain
Clinical Trials (36)
A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)
A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.
Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy
A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain
A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis
A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis
A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy
Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain
A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia
A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain.
A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.
Study to Assess Food Effect on Sativex Bioavailability
Abuse Potential of Sativex
A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients
A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis
A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients
A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma
Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients
A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 36